MLH1 and Lynch syndrome: An additional issue to be discussed for future directions in clinical screening for Lynch syndrome is the possibility of MLH1 hypermethylation in Lynch syndrome patients who are carriers of a pathogenic MLH1 germline variant [36,37,38] or who are carriers of a constitutional, possibly hereditary, MLH1 epimutation [36,39,40,41].